NeuroPace Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
NPCE$12.69-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Stockholders' Equity
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Total Stockholders’ Equity | |||||
|---|---|---|---|---|---|
| (in thousands, except share amounts) · Shares · Amount | |||||
| Balances as of January 1, 2024 | 27,823,465 | $28 | $524,435 | $(503,809) | $20,654 |
| Net loss | — | — | — | (8,925) | (8,925) |
| Issuance of common stock pursuant to stock option exercises | 409,045 | — | 721 | — | 721 |
| Issuance of common stock upon vesting of restricted stock units | 522,483 | 1 | (1) | — | — |
| Shares withheld for taxes | (37,541) | — | (649) | — | (649) |
| Stock-based compensation | — | — | 2,540 | — | 2,540 |
| Balances as of March 31, 2024 | 28,717,452 | 29 | 527,046 | (512,734) | 14,341 |
| Net loss | — | — | — | (7,514) | (7,514) |
| Issuance of common stock pursuant to stock option exercises | 95,008 | — | 53 | — | 53 |
| Issuance of common stock pursuant to Employee Stock Purchase Plan | 94,743 | — | 528 | — | 528 |
| Issuance of common stock upon vesting of restricted stock units | 242,518 | — | — | — | — |
| Shares withheld for taxes | (9,233) | — | (72) | — | (72) |
| Repurchase of common stock | (1,282) | — | — | — | — |
| Change in early exercise liability | — | — | 1 | — | 1 |
| Stock-based compensation | — | — | 2,548 | — | 2,548 |
| Balances as of June 30, 2024 | 29,139,206 | 29 | 530,104 | (520,248) | 9,885 |
| Net loss | — | — | — | (5,452) | (5,452) |
| Issuance of common stock pursuant to stock option exercises | 15,261 | — | 34 | — | 34 |
| Issuance of common stock as part of At-the-Market offering, net of sales commission and offering expenses of $189 | 413,988 | 1 | 2,832 | — | 2,833 |
| Issuance of common stock upon vesting of restricted stock units | 218,743 | — | — | — | — |
| Shares withheld for taxes | (9,232) | — | (68) | — | (68) |
| Stock-based compensation | — | — | 2,591 | — | 2,591 |
| Balances as of September 30, 2024 | 29,777,966 | $30 | $535,493 | $(525,700) | $9,823 |
Condensed Statements of Stockholders’ Equity
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| (in thousands, except share amounts) · Shares · Amount | ||||||
| Balances as of January 1, 2023 | 25,045,751 | $25 | $506,713 | $(1,108) | $(470,853) | $34,777 |
| Net loss | — | — | — | — | (10,375) | (10,375) |
| Unrealized loss adjustment for short-term investment | — | — | — | 1,108 | — | 1,108 |
| Issuance of common stock pursuant to stock option exercises | 17,608 | — | 1 | — | — | 1 |
| Issuance of common stock upon vesting of restricted stock units | 325,747 | — | — | — | — | — |
| Shares withheld for taxes | (35,562) | — | (146) | — | — | (146) |
| Repurchase of common stock | (1,340) | — | — | — | — | — |
| Stock-based compensation | — | — | 2,125 | — | — | 2,125 |
| Balances as of March 31, 2023 | 25,352,204 | 25 | 508,693 | — | (481,228) | 27,490 |
| Net loss | — | — | — | — | (9,124) | (9,124) |
| Issuance of common stock pursuant to stock option exercises | 164,134 | 1 | 4 | — | — | 5 |
| Issuance of common stock pursuant to Employee Stock Purchase Plan | 164,710 | — | 240 | — | — | 240 |
| Issuance of common stock upon vesting of restricted stock units | 145,787 | — | — | — | — | — |
| Shares withheld for taxes | (9,906) | — | (41) | — | — | (41) |
| Change in early exercise liability | — | — | 1 | — | — | 1 |
| Stock-based compensation | — | — | 2,655 | — | — | 2,655 |
| Balances as of June 30, 2023 | 25,816,929 | 26 | 511,552 | — | (490,352) | 21,226 |
| Net loss | — | — | — | — | (7,257) | (7,257) |
| Issuance of common stock pursuant to stock option exercises | 313,107 | — | 8 | — | — | 8 |
| Issuance of common stock upon vesting of restricted stock units | 119,164 | — | — | — | — | — |
| Shares withheld for taxes | (4,265) | — | (35) | — | — | (35) |
| Stock-based compensation | — | — | 2,421 | — | — | 2,421 |
| Balances as of September 30, 2023 | 26,244,935 | $26 | $513,946 | $— | $(497,609) | $16,363 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.